Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Sep;10(9):489-490.
doi: 10.1158/1940-6207.CAPR-17-0197. Epub 2017 Aug 18.

When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials

Daniel E Johnson  1 , Julie E Bauman  2
Affiliations
Editorial

When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials

Daniel E Johnson et al. Cancer Prev Res (Phila). 2017 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Comment on

References

    1. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235–42. - PMC - PubMed
    1. Boing AF, Antunes JL, de Carvalho MB, de Gois Filho JF, Kowalski LP, Michaluart P, Jr, et al. How much do smoking and alcohol consumption explain socioeconomic inequalities in head and neck cancer risk? J Epidemiol Community Health. 2011;65:709–14. - PubMed
    1. Sheth SH, Johnson DE, Kensler TW, Bauman JE. Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions. Oral Oncol. 2015;51:557–64. - PubMed
    1. Bauman JE, Grandis J. Oral cancer chemoprevention–The end of EPOC, the beginning of an epoch of molecular selection. JAMA Oncol. 2016;2:178–9. - PubMed
    1. William WN, Jr, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, et al. Erlotinib and the risk of oral cancer: the erlotinib prevention of oral cancer (EPOC) randomized clinical trial. JAMA Oncol. 2016;2:209–16. - PMC - PubMed

LinkOut - more resources